ZA945278B - Melanoma-inhibiting protein - Google Patents

Melanoma-inhibiting protein

Info

Publication number
ZA945278B
ZA945278B ZA945278A ZA945278A ZA945278B ZA 945278 B ZA945278 B ZA 945278B ZA 945278 A ZA945278 A ZA 945278A ZA 945278 A ZA945278 A ZA 945278A ZA 945278 B ZA945278 B ZA 945278B
Authority
ZA
South Africa
Prior art keywords
iib
iia
protein
melanoma
htz
Prior art date
Application number
ZA945278A
Other languages
English (en)
Inventor
Ulrich Prof Dr Bogdahn
Reinhard Dr Buettner
Brigitte Dipl Biol Dr Kaluza
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA945278B publication Critical patent/ZA945278B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA945278A 1993-07-20 1994-07-19 Melanoma-inhibiting protein ZA945278B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4324247 1993-07-20

Publications (1)

Publication Number Publication Date
ZA945278B true ZA945278B (en) 1996-01-19

Family

ID=6493222

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945278A ZA945278B (en) 1993-07-20 1994-07-19 Melanoma-inhibiting protein

Country Status (14)

Country Link
US (1) US5770366A (fr)
EP (2) EP0710248B1 (fr)
JP (1) JP3435163B2 (fr)
CN (1) CN1056617C (fr)
AT (1) ATE185152T1 (fr)
AU (1) AU7531294A (fr)
CA (1) CA2167693C (fr)
DE (2) DE59408791D1 (fr)
DK (1) DK0710248T3 (fr)
ES (1) ES2139751T3 (fr)
GR (1) GR3032212T3 (fr)
IL (2) IL154248A (fr)
WO (1) WO1995003328A2 (fr)
ZA (1) ZA945278B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653358A1 (de) * 1996-12-20 1998-06-25 Boehringer Mannheim Gmbh Immunoassay zum Nachweis von MIA
AU5923398A (en) 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
USRE39920E1 (en) 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
US6492144B1 (en) * 1997-05-30 2002-12-10 Diagen Corporation Methods for detection of nucleic acid sequences in urine
EP0945507A1 (fr) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Region de régulation d'expression spécifique de tumeur et son utilisation
US20020103360A1 (en) * 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
US20030072767A1 (en) * 1998-09-30 2003-04-17 Alexander Gaiger Compositions and methods for WT1 specific immunotherapy
EP1025871A1 (fr) * 1999-01-28 2000-08-09 F. Hoffmann-La Roche Ag Utilisation d'un facteur à activité inhibitrice du mélanome pour la réparation de cartilage et des os
US6713293B1 (en) * 1999-02-08 2004-03-30 Friedrich Grummt Encapsulated cells containing an amplified expression vector as a drug delivery device
PL353065A1 (en) * 1999-06-30 2003-10-06 Takeda Chemical Industries, Ltd. Novel polypeptide and dna thereof
AU2001232967A1 (en) * 2000-01-25 2001-08-07 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
EP1133994A1 (fr) * 2000-03-11 2001-09-19 Biognostik Gesellschaft für biomolekulare Diagnostik mbH Méthode pour inverser les effets d' immunosuppression de MIA (Melanoma Inhibitory Activity)
WO2001070253A1 (fr) * 2000-03-23 2001-09-27 Akzo Nobel N.V. Utilisation de la proteine mia dans l'immunotherapie
US6613534B2 (en) 2001-03-20 2003-09-02 Wake Forest University Health Sciences MAP-2 as a determinant of metastatic potential
US20100212037A1 (en) * 2002-10-16 2010-08-19 Anja Katrin Bosserhoff Mia-2 protein
KR20090046893A (ko) * 2006-07-28 2009-05-11 노파르티스 아게 흑색종에서 치료학적 반응에 대한 조기 지표로서의 흑색종 억제 활성 (ｍｉａ) 단백질의 용도
CA2696403C (fr) * 2007-08-22 2018-01-02 Xenomics, Inc. Procedes d'utilisation d'arnmi pour la detection de la mort cellulaire in vivo
EP2563809B1 (fr) 2010-04-27 2020-04-01 Scil Technology GmbH Préparation aueuse stable de mia/cd-rap
CN103025875A (zh) * 2010-08-30 2013-04-03 霍夫曼-拉罗奇有限公司 原核表达构建体
ITRM20110134A1 (it) * 2011-03-22 2012-09-23 Matteo Bordignon Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine

Also Published As

Publication number Publication date
EP0710248A1 (fr) 1996-05-08
AU7531294A (en) 1995-02-20
IL110385A (en) 2003-12-10
EP0947583A3 (fr) 2000-05-03
IL110385A0 (en) 1994-10-21
CA2167693C (fr) 2007-01-30
DK0710248T3 (da) 2000-04-10
GR3032212T3 (en) 2000-04-27
CA2167693A1 (fr) 1995-02-02
WO1995003328A2 (fr) 1995-02-02
CN1056617C (zh) 2000-09-20
ATE185152T1 (de) 1999-10-15
IL154248A0 (en) 2003-09-17
JPH09500531A (ja) 1997-01-21
ES2139751T3 (es) 2000-02-16
EP0947583A2 (fr) 1999-10-06
DE59408791D1 (de) 1999-11-04
US5770366A (en) 1998-06-23
DE4425481A1 (de) 1995-03-02
EP0710248B1 (fr) 1999-09-29
JP3435163B2 (ja) 2003-08-11
IL154248A (en) 2008-08-07
CN1133049A (zh) 1996-10-09
WO1995003328A3 (fr) 1995-03-16

Similar Documents

Publication Publication Date Title
GR3032212T3 (en) Melanoma-inhibiting protein
ZA200005843B (en) New nucleotide sequences which code for the pck gene.
GR3019043T3 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
EP1209237A3 (fr) Séquence d'ADN synthétique ayant une action insecticide accrue dans le mais
AU7587696A (en) Differentiation-suppressive polypeptide
HK1004150A1 (en) Calcium free subtilisin mutants.
CA2204257A1 (fr) Tripeptidyl aminopeptidase
CA2102702A1 (fr) Carboxylase dependante de la vitamine k
CA2188279A1 (fr) Recepteurs de l'interleukine-15
CA2252493A1 (fr) Gene de la .beta.-galactoside - .alpha. 2,6-sialyltransferase
EP0479071A3 (en) Polypeptide
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
CA2191222C (fr) Adn codant la bacillus licheniformis pwd-1 keratinase
AU2898995A (en) Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant
AU7949991A (en) Cloned n-methylhydantoinase
CA2301902A1 (fr) Nouvelle serine protease extracellulaire
CA2155332A1 (fr) Polypeptide presentant une activite de pyruvate-phosphate-dikinase induisant une resistance au froid, adn codant pour ce polypeptide, et vecteur de recombinaison et plante transformee contenant tous les deux ledit adn
AU6659896A (en) Protein with plant protecting properties
CA2144601A1 (fr) Collagenase recombinante de type ii issue de clostridium hystolyticum et son utilisation pour l'isolement de cellules et de groupes de cellules
AU5637298A (en) Novel cytochrome P450 gene
ES8700694A1 (es) Un procedimiento para producir un polipeptido de interferon hibrido antivirico y antiproliferante
EP0477791A3 (en) Polypeptide
ATE398681T1 (de) Nukleotidsequenzen die für das mene-gen kodieren
MX9605473A (es) Polipeptido hk2 recombinante.
ES2023538A6 (es) Procedimiento de obtencion y purificacion del fragmento carboxilo-terminal de la dna polimerasa i de streptococcus pneumoniae